Laser ablation process and apparatus

• US 4,785,806 A
• Filed: 01/08/1987
• Issued: 11/22/1988
• Est. Priority Date: 01/08/1987
• Status: Expired due to Fees

• Current Assignee: Yale University
• Original Assignee: Yale University
• Inventors: Deckelbaum, Lawrence I.
• Primary Examiner(s): Cohen, Lee S.
• Assistant Examiner(s): SHAY, DAVID M
• Application Number:
  US07/001,376
• Time in Patent Office: 684 Days
• Field of Search: 128/303.1, 128/395, 128/634, 128/653, 128/665-667, 219/121 L, 219/121 LA, 219/121 LB, 219/121 LM, 604/20
• US Class Current: 606/7
• CPC Class Codes: A61B 18/20 using laser
• CPC Class Codes: A61B 18/245 for removing obstructions in blood vessels or calculi
• CPC Class Codes: A61B 2017/00057 Light
• CPC Class Codes: A61B 2018/00636 Sensing and controlling the application of energy

Abstract

A process and apparatus for ablating atherosclerotic or tumorous tissues is disclosed. Optical fibers direct low power light energy at a section of tissue to be ablated to cause the section to fluoresce. The fluorescence pattern is analyzed to determine whether the fluorescence frequency spectrum is representative of normal or abnormal tissue. A source of high power ultraviolet laser energy directed through an optical fiber at the section of tissue is fired only when the fluorometric analysis indicates that it is directed at abnormal tissue.

Claims

1. Apparatus for ablating atherosclerotic tissue in blood vessels, comprising:

a source of low power ultraviolet laser energy having a wavelength outside the band of visible wavelengths,

fiberoptic means for directing said low power laser energy at a section of tissue of said blood vessel to cause said section to fluoresce,

spectrum analyzing means for determining whether a laser induced fluorescence frequency spectrum is representative of normal or atherosclerotic tissue,

a source of high power laser energy for producing pluses, the pulse duration and energy per unit area of which are selected to cause ablation without charring of tissue that would obscure the fluorescence pattern of the tissue,

fiber optic means for directing the output of said high power ultraviolet laser at said section of tissue, and

means responsive to said spectrum analyzing means for enabling atherosclerotic tissue to be progressively ablated by said high power laser energy while said tissue is caused to fluoresce by said low power ultraviolet laser until said spectrum analyzing means indicates that the fluorescence pattern of said tissue is no longer indicative of atherosclerotic tissue thereby to ablate said atherosclerotic tissue only.

2. Apparatus according to claim 1, wherein said source of high power laser energy comprises a pulsed laser, the output of which has a wavelength between 280 nm and 400 nm, a pluse duration between 10 and 500 ns and wherein the pulse energy per unit area is greater than 20 mJ/mm².

3. Apparatus according to claims 1 or 2, wherein said two fiber optic means comprise a central fiber for said high power source and a plurality of optical fibers for said low power source enveloping said central fiber.

4. Apparatus according to claims 1 or 2, wherein said two fiberoptic means comprise a single fiber.

5. Apparatus according to claim 2, wherein the pulse energy per unit area of the pulses produced by said high power laser is greater than 35 mJ/mm² and the frequency of the laser is in the near ultraviolet range.

6. A method for ablating atherosclerotic plaque, comprising:

directing a low power ultraviolet laser having a wavelength outside the band of visible wavelengths at a selected section of a blood vessel to cause fluorescence of the tissue in said section,

analyzing the frequency spectrum of such fluorescence to determine whether the section of the blood vessel at which said low power laser is directed is normal or atherosclerotic,

providing a high power laser having an output in the form of pulses, the pulse duration and pulse energy per unit area of said pulses being selected so as to cause ablation without charring,

directing the pulses from said high power laser at said section if said step of analyzing the frequency spectrum indicates that said section is atherosclerotic,

continuing to irradiate the tissue with said low power ultraviolet laser energy to cause said tissue to fluoresce,

analyzing the fluorescence spectrum as the tissue is caused to fluoresce, and

discontinuing the laser ablation process when the fluorescence pattern of the tissue indicates that it is no longer atherosclerotic.

7. A method according to claim 6, wherein the step of providing a high power laser comprises providing a laser having an output in the form of pulses having a pulse energy per unit area greater than 35 mJ/mm².

8. A method according to claim 6, wherein the step of providing a high power laser comprises providing a laser having an output in the form of pulses having a wavelength between 280 nm and 400 nm and a pulse duration between 10 ns and 500 ns, the pulse energy per unit area being greater than 20 mJ/mm².

9. A method according to claim 8 wherein the pulse energy per unit area is greater than 35 mJ/mm².